1. Guidance for the identification of endocrine disruptors in thecontext of Regulations (EU) No 528/2012 and (EC) No 1107/2009;Andersson;EFSA Journal 2018,2018
2. Oppts 890.1550: steroidogenesis (human cell line H295R). Office of prevention, and toxic substances;Endocrine Disruptor Screening Program Test Guidelines,2009
3. Oppts 890.1200: aromatase assay (human recombinant). Office of prevention, and toxic substances;Endocrine Disruptor Screening Program Test Guidelines,2009
4. OPPTS 890.1450: Pubertal Development and Thyroid Function in Intact Juvenile/Peripubertal Female Rats. Office of Prevention, and Toxic Substances. Docket #EPA-HQ-OPPT-2009-05676-0009.Pdf, Endocrine Disruptor Screening Program Test Guidelines,2011
5. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis;Gazdar;Cancer Res.,1990